An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues

Information

  • Research Project
  • 9778131
  • ApplicationId
    9778131
  • Core Project Number
    R44OD020163
  • Full Project Number
    2R44OD020163-02A1
  • Serial Number
    020163
  • FOA Number
    PA-18-574
  • Sub Project Id
  • Project Start Date
    8/16/2015 - 9 years ago
  • Project End Date
    8/31/2021 - 3 years ago
  • Program Officer Name
    CONTRERAS, MIGUEL A
  • Budget Start Date
    9/1/2019 - 5 years ago
  • Budget End Date
    8/31/2020 - 4 years ago
  • Fiscal Year
    2019
  • Support Year
    02
  • Suffix
    A1
  • Award Notice Date
    9/1/2019 - 5 years ago
Organizations

An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues

Summary The mission of CryoCrate LLC (www.CryoCrate.com) is to develop new platform cryopreservation technologies for applications in life science and clinical practice. With recent rapid advances in cell-based tissue engineering and regenerative medicine, as well as continued development of transplantation technologies, there has always been an urgent need for clinically practical methods and efficient devices for cryopreservation of large stocks of bioartificial and donor tissues. In the Phase I period of this project, we successfully established a novel ultra-fast cooling method (106K/min on cellular level) for small tissues. In the Phase II period, we will: 1) design an upgraded device system that achieves the same efficiency for cryopreservation of the whole corneas and large bioartificial tissues and facilitate their clinical and research use; 2) produce the device as a mature product by working with a professional manufacturer (Gateway Discovery Products LLC) and cGMP consultant (Cardinal Health); and 3) test the post-thaw in-vitro viability and functionalities of the corneas and bioartificial retinal tissues, and conduct in-vivo animal studies on rabbits (Vision Research Center at UMKC). After achieving these milestones, we will work with our eye bank collaborator (Saving Sight), current distributor (Mayflower Bioscience), and potential strategic partner (Thermo Fisher Scientific) to introduce the product to corneal transplantation and tissue engineering markets.

IC Name
OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH
  • Activity
    R44
  • Administering IC
    OD
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    815083
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    351
  • Ed Inst. Type
  • Funding ICs
    OD:815083\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    CRYOCRATE, LLC
  • Organization Department
  • Organization DUNS
    078602139
  • Organization City
    COLUMBIA
  • Organization State
    MO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    652110001
  • Organization District
    UNITED STATES